INCB054828 (pemigatinib), a potent and selective inhibitor of fibroblast growth factor receptors 1, 2, and 3, displays activity against genetically defined tumor models-Reference-Cited by-同舟云学术

INCB054828 (pemigatinib), a potent and selective inhibitor of fibroblast growth factor receptors 1, 2, and 3, displays activity against genetically defined tumor models

Published:2020-04-21 Issue:4 Volume:15 Page:e0231877
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Liu Phillip C. C.,Koblish Holly,Wu Liangxing,Bowman Kevin,Diamond Sharon,DiMatteo Darlise,Zhang Yue,Hansbury Michael,Rupar Mark,Wen Xiaoming,Collier Paul,Feldman Patricia,Klabe Ronald,Burke Krista A.,Soloviev Maxim,Gardiner Christine,He Xin,Volgina Alla,Covington Maryanne,Ruggeri Bruce,Wynn Richard,Burn Timothy C.,Scherle Peggy,Yeleswaram Swamy,Yao Wenqing,Huber Reid,Hollis Gregory

Funder

Incyte Corporation

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference43 articles.

1. Hallmarks of cancer: the next generation;D Hanahan;Cell,2011

2. The hallmarks of cancer;D Hanahan;Cell,2000

3. Cell signaling by receptor tyrosine kinases;MA Lemmon;Cell,2010

4. Comprehensive characterization of cancer driver genes and mutations;MH Bailey;Cell,2018

5. Clinical targeting of mutated and wild-type protein tyrosine kinases in cancer;JM Drake;Mol Cell Biol,2014

Cited by 132 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synthesis and identification of a selective FGFR2 degrader with potent antiproliferative effects in gastric cancer;European Journal of Medicinal Chemistry;2024-11

2. Precision oncology targeting FGFRs: A systematic review on pre-clinical activity and clinical outcomes of pemigatinib;Critical Reviews in Oncology/Hematology;2024-10

3. Design, synthesis and biological evaluation of 5-amino-1H-pyrazole-4-carboxamide derivatives as pan-FGFR covalent inhibitors;European Journal of Medicinal Chemistry;2024-09

4. Overcoming treatment resistance in cholangiocarcinoma: current strategies, challenges, and prospects;Frontiers in Cell and Developmental Biology;2024-08-02

5. Myeloid/lymphoid neoplasms with eosinophilia and FGFR1 rearrangement t(8;13)(p11;q12): A case report and literature review;Oncology Letters;2024-07-31